Shanghai MicroPort Endovascular MedTech (688016.SS) Earnings Analysis
Shanghai MicroPort Endovascular MedTech (688016.SS) next reports earnings on 2026-08-27. It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 18.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688016.SS next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.37B |
688016.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 1.26 CNY | n/a | n/a | n/a |
| 2026-02-28 | 1.11 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.946 CNY | n/a | n/a | n/a |
| 2024-08-26 | 1.77 CNY | 1.24 CNY | +42.7% | Beat |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
688016.SS valuation and analyst view
| Trailing P/E | 18.76 |
|---|---|
| Trailing EPS | 4.864 CNY |
| Price / book | 2.62 |
| Dividend yield | 2.52% |
| Market cap | 11.10B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai MicroPort Endovascular MedTech (688016.SS)'s next earnings date?
Shanghai MicroPort Endovascular MedTech is next scheduled to report on 2026-08-27 and revenue estimate of 0.37B.
Did 688016.SS beat earnings last quarter?
Consensus estimate data was not available for 688016.SS's 2026-04-30 report.
What is 688016.SS's earnings track record?
Over the last 1 reported quarters with consensus data, 688016.SS beat estimates 1 times (100%).
What is 688016.SS's current P/E ratio and EPS?
688016.SS trades at a trailing P/E of 18.76 on trailing EPS of 4.864155948962127 CNY.
What do analysts rate 688016.SS?
688016.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.